Certificate number:RU.77.99.11.003.E.051242.11.11
Date of registration and renewal:17.11.2011
Dosage form: & nbspTabletki with a mass of 6.5 g ± 130 mg
Classification "Composition" & nbsp Dietary supplements - proteins, amino acids and their derivatives Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances Supplements containing potassium and magnesium
Composition: & nbspIngredients: magnesium carbanate, ascorbic acid Auxiliary components: citric acid (E330), sodium hydrogen carbonate (E500), maltodextrin (E1400), lemon scent flavoring, sorbitol (E420), sodium saccharin (E954), riboflavin (E101)
Scope: & nbspDFor sale to the population through the pharmacy network and specialized stores, the sales network departments as a biologically active food additive - an additional source of magnesium, vitamins C, B2 (APPENDIX)
Suggested Usage: & nbspAT1 tablet a day 1 times a day during meals, previously dissolving the tablet in 1 glass (200 ml) of water. Duration of admission is 20 days. If necessary, the reception can be repeated.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding. It is not recommended for people with a predilection for bowel function disorders.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions: Store in a dry place, protected from light, out of reach of children, at a temperature not exceeding + 25 ° ะก.
Research protocols:EThe Federal Agency for the Federal Treasury and Federal Service for Consumer Protection of the Russian Federation No. 10-2FTS / 2001 dated April 19, 2010
Recipient:HEMOFARM JOINT STOCK COMPANY PHARMACEUTICAL AND CHEMICAL INDUSTRYHEMOFARM JOINT STOCK COMPANY PHARMACEUTICAL AND CHEMICAL INDUSTRY
Information update date: & nbsp14.07.2016
Instructions
Up